SCHEMBL24933765

SCHEMBL24933765

OC/C=C\COC[C@H](O)COc1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
MAPK1 P28482 2/20 0.45
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30896281 1.00 MAPT (0.47) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL29203434 1.00 MAPT (0.47) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL24933345 0.82 CYP2D6 (0.50) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL24933047 0.82 CYP2D6 (0.50) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL7225393 0.79 LSS (0.47) ALDH1A1KMT2AMEN1POLB
SCHEMBL7225391 0.79 LSS (0.47) ALDH1A1KMT2AMEN1POLB
SCHEMBL24933773 0.76 MAPT (0.47) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL30896305 0.76 MAPT (0.47) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL29203464 0.76 MAPT (0.47) MAPTMAPK1KDM4ETDP1ALDH1A1
SCHEMBL1496588 0.76 MAPT (0.58) MAPTMAPK1KDM4ETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed